TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)

Hammel, P; Berardi, R; Van Cutsem, E; Feliu, J; Greil, R; Wasan, HS; Metges, JP; Nygren, P; Osterlund, PJ; Noel, MS; Seufferlein, T; Creemers, GY; Gupta, A; Salesse, S; Biswas-Baldwin, N; Dion, H; Youssoufian, H; Garzon, FT; El-Hariry, I; Hidalgo, M

View this publication in the PUBMED database